Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Cardiopulmonary By-pass System That Minimizes Haemodilution, Hemolysis and Systemic Inflammation. Effects on Organ Damage and Surgical Outcome

NCT01805466 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.

NCT NCT01805466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01805466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Cardiopulmonary By-pass System That Minimizes Haemodilution, Hemolysis and Systemic Inflammation. Effects on Organ Damage and Surgical Outcome
Lead sponsor
IRCCS San Raffaele Roma
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2012
Completion date
July 31, 2013
Enrollment
300 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

c.surgical procedure; cardiac